Willow Biosciences Inc. announced entry into a follow-on Master Services Agreement to develop an enzyme used in biocatalytic production of a new, advanced ingredient used in natural beverage applications. This marks the second collaborative development program the two parties have engaged on following the announcement of an MSA on November 8, 2022 for which Willow has already successfully achieved development goals in short order. Willow's FutureGrown(TM) technology platform is a fully integrated, proven solution for rapid enzyme and strain engineering, process development and scaled-up manufacturing that incorporates the latest technologies available for precision fermentation.

Kalsec's projects focus on yeast, which, among other applications, is an ideal host for production of numerous ingredients for the food and beverage sector. By working closely with their customers, the development team at Kalsec has identified multiple potential opportunities for collaboration and innovation in this space.